Is autoimmunity coming to a Fas (t) end?
Is autoimmunity coming to a Fas(t) end? | Nature Medicine Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the
best experience, we recommend you use a more up to date browser (or turn off compatibility
mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying
the site without styles and JavaScript. Advertisement Nature Medicine View all journals Search
My Account Explore content About the journal Publish with us Sign up for alerts RSS feed …
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the
best experience, we recommend you use a more up to date browser (or turn off compatibility
mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying
the site without styles and JavaScript. Advertisement Nature Medicine View all journals Search
My Account Explore content About the journal Publish with us Sign up for alerts RSS feed …
Abstract
Using bisindolylmaleimide to enhance the suicide program of activated lymphocytes is a novel therapeutic approach to the treatment of autoimmune disease (pages 42–48 and 90–96).
nature.com
